4bases kits work on all first generation and next generation systems. Current 4bases kits for breast, ovarian, colorectal, lung and thyroid cancer are designed to identify genetic anomalies of the cancer to direct drug therapy decisions. 4bases has developed also a kit for the investigation of hereditary mutations involved in breast and ovarian cancer predisposition. In addition, 4bases will design and produce diagnostic assays based on NGS technology for no oncological diseases.


Companion diagnostic assays in oncology

Read more +

CE-IVD data analysis software

Read more +